Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04009421 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Coronary Artery Plaque Burden in Stable Angina and Non-obstructive Coronary Artery Disease

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv5
  2. Primary completion date: Dec 2022 to Dec 2028
    • Study completion date: Jan 2023 to Dec 2028
    v4
  3. Primary completion date: Jan 2022 to Dec 2022v3
  4. Primary endpoint revised
    • Secondary endpoint revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Non-obstructive coronary artery disease (CAD), particularly common in women, has been associated with impaired quality of life and risk of recurrent hospitalizations. Several studies have also demonstrated increased risk of incident acute coronary events and mortality. The main objective of the project is to assess the association between coronary artery plaque features by coronary CT angiography and long term prognosis in a large unselected population undergoing CT coronary angiography due to stable angina and suspected myocardial ischemia from the Norwegian Registry for Invasive Cardiology (NORIC) diagnosed with non-obstructive CAD by coronary CT angiography.
Trial Details
NCT Number NCT04009421
Lead Sponsor University of Bergen
Collaborators: Haukeland University Hospital
Conditions
(from sponsor)		 Coronary Artery Disease, Plaque, Atherosclerotic
Related terms Coronary Artery Disease, Plaque, Atherosclerotic
Enrollment 1,400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov